Dianthus Therapeutics, Inc. /DE/ (DNTH) › Net IncomeDianthus Therapeutics, Inc. /DE/ (DNTH) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: -$9.43M2017: -$35.49M2018: -$57.52M2019: -$76.77M2020: -$74.94M2021: -$71.14M2022: -$28.48M2023: -$43.55M2024: -$84.97M2025: -$162.34M-$162.34M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$162.34M-91.1%2024-$84.97M-95.1%2023-$43.55M-53.0%2022-$28.48M+60.0%2021-$71.14M+5.1%2020-$74.94M+2.4%2019-$76.77M-33.5%2018-$57.52M-62.1%2017-$35.49M-276.3%2016-$9.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share